Corveus Medical
UEI: GFC9AFW64C11
• CAGE: 946B0
Overview
Awardee Type
Parent
Company Description
Corveus Medial is based in Houston, Texas and is developing a minimally-invasive solution to congestive heart failure. Our device deactivates a nerve that has been demonstrated to be a driver behind heart failure, allowing physicians to treat patients that has traditionally had little to no options and improve quality of life.
Name
Corveus Medical
Website
Headquarters
Houston, TX
United States
United States
Most Recent Award
March 1, 2023
Calculating
Federal grant recipient
CORVEUS MEDICAL, INC.
(UEI GFC9AFW64C11, CAGE 946B0)
is headquartered in Houston TX.
The corporation
was founded in April 2021 and
federally registered in
August 2021.
Federal Award Analysis
Corveus Medical federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
CORVEUS MEDICAL, INC.
UEI
GFC9AFW64C11
CAGE Code
946B0
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
April 15, 2021
Initial Registration
Aug. 2, 2021
Last Registration
Dec. 2, 2024
Registration Activation
Nov. 27, 2024
Registration Expiration
Nov. 25, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Reported NAICS
None Reported
Accepts Credit Cards
No